Cargando…

Impact of prostate focused alignment on planned pelvic lymph node dose

PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kilian‐Meneghin, Joshua, Ma, Tianjun, Kumaraswamy, Lalith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292696/
https://www.ncbi.nlm.nih.gov/pubmed/34231945
http://dx.doi.org/10.1002/acm2.13092
_version_ 1783724876588122112
author Kilian‐Meneghin, Joshua
Ma, Tianjun
Kumaraswamy, Lalith
author_facet Kilian‐Meneghin, Joshua
Ma, Tianjun
Kumaraswamy, Lalith
author_sort Kilian‐Meneghin, Joshua
collection PubMed
description PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered using portal‐imaging. However, the pelvic lymph nodes are affixed to the bony anatomy and are not mobile in concert with the prostate. The aim of this study was to determine whether a significant difference in pelvic lymph node coverage exists between planned and delivered external beam therapy treatments for these patients. METHODS: The recorded prostate motions were gathered for 19 patients; conjointly the pelvic lymph node motions were determined by manual registration of the bony anatomy in the kV‐images. The difference between the prostate and the bony anatomy coordinates was input into Eclipse as field shifts to represent the deviation in planned vs delivered pelvic lymph node coverage. RESULTS: Structure volume at V(100) was recorded for each patient for two structures: summed pelvic lymph nodes (LN CTV) and pelvic lymph nodes +1 cm margin (LN PTV) to express their contribution to the PTV. For the LN PTV, the average difference between the planned coverage and calculated delivered coverage was 3.5%, with a paired t‐test value of P = 0.005. Based upon bony anatomy registration, 26% of patients received less than 95% dose coverage using V(100) criteria for LN PTV. Dose value differences between the two plans at minimum were 6.96 ± 6.23 Gy, at mean were 0.54 ± 0.40 Gy, and at maximum were 0.10 ± 0.29 Gy. For the LN CTV, the average difference between the planned coverage and calculated delivered coverage was 1%, with a paired t‐test value of P = 0.53. CONCLUSIONS: The results indicate a significant difference exists between the planned coverage and calculated delivered coverage for the LN PTV. There was no significant difference found for the LN CTV. We conclude that lymph node motion must be considered with the prostate motion when aligning patients before each fraction.
format Online
Article
Text
id pubmed-8292696
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82926962021-07-22 Impact of prostate focused alignment on planned pelvic lymph node dose Kilian‐Meneghin, Joshua Ma, Tianjun Kumaraswamy, Lalith J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Prostate patients with positive lymph node margins receive an initial course of 45 Gy to the planning target volume (PTV) comprised of prostate, seminal vesicles, and lymph nodes with a 1‐cm margin. The prostate is localized via implanted fiducial markers before each fraction is delivered using portal‐imaging. However, the pelvic lymph nodes are affixed to the bony anatomy and are not mobile in concert with the prostate. The aim of this study was to determine whether a significant difference in pelvic lymph node coverage exists between planned and delivered external beam therapy treatments for these patients. METHODS: The recorded prostate motions were gathered for 19 patients; conjointly the pelvic lymph node motions were determined by manual registration of the bony anatomy in the kV‐images. The difference between the prostate and the bony anatomy coordinates was input into Eclipse as field shifts to represent the deviation in planned vs delivered pelvic lymph node coverage. RESULTS: Structure volume at V(100) was recorded for each patient for two structures: summed pelvic lymph nodes (LN CTV) and pelvic lymph nodes +1 cm margin (LN PTV) to express their contribution to the PTV. For the LN PTV, the average difference between the planned coverage and calculated delivered coverage was 3.5%, with a paired t‐test value of P = 0.005. Based upon bony anatomy registration, 26% of patients received less than 95% dose coverage using V(100) criteria for LN PTV. Dose value differences between the two plans at minimum were 6.96 ± 6.23 Gy, at mean were 0.54 ± 0.40 Gy, and at maximum were 0.10 ± 0.29 Gy. For the LN CTV, the average difference between the planned coverage and calculated delivered coverage was 1%, with a paired t‐test value of P = 0.53. CONCLUSIONS: The results indicate a significant difference exists between the planned coverage and calculated delivered coverage for the LN PTV. There was no significant difference found for the LN CTV. We conclude that lymph node motion must be considered with the prostate motion when aligning patients before each fraction. John Wiley and Sons Inc. 2021-07-07 /pmc/articles/PMC8292696/ /pubmed/34231945 http://dx.doi.org/10.1002/acm2.13092 Text en © 2021 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Kilian‐Meneghin, Joshua
Ma, Tianjun
Kumaraswamy, Lalith
Impact of prostate focused alignment on planned pelvic lymph node dose
title Impact of prostate focused alignment on planned pelvic lymph node dose
title_full Impact of prostate focused alignment on planned pelvic lymph node dose
title_fullStr Impact of prostate focused alignment on planned pelvic lymph node dose
title_full_unstemmed Impact of prostate focused alignment on planned pelvic lymph node dose
title_short Impact of prostate focused alignment on planned pelvic lymph node dose
title_sort impact of prostate focused alignment on planned pelvic lymph node dose
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292696/
https://www.ncbi.nlm.nih.gov/pubmed/34231945
http://dx.doi.org/10.1002/acm2.13092
work_keys_str_mv AT kilianmeneghinjoshua impactofprostatefocusedalignmentonplannedpelviclymphnodedose
AT matianjun impactofprostatefocusedalignmentonplannedpelviclymphnodedose
AT kumaraswamylalith impactofprostatefocusedalignmentonplannedpelviclymphnodedose